We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Guidance for the pharmaceutical industry on how to apply to vary a veterinary Marketing Authorisation (MA) or Homeopathic Remedy.
How the MHRA processes variations to Marketing Authorisations (MAs)
The New Variant Assessment Platform (NVAP) is an offer of UK capacity and expertise to detect and assess new variants of SARS-CoV-2 around the world.
Forms to make a variation to a manufacturer's licence.
Information and guidance for variations in names.
A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies
Who in the pharmaceutical industry can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
How to prepare for implementation and compliance of the Safety Features Regulation.
Use form IOV2 to work out whether a 'variation' to the will will meet all the necessary legal requirements.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).